Brown, J. R., Ghia, P., Jurczak, W., Kahl, B. S., Lamanna, N., Robak, T., Shadman, M., Tam, C. S., Qiu, L., Paik, J., Salmi, T., Wang, L., Zhang, J., Zhang, M., Cohen, A., Ma, H., & Tedeschi, A. (2024). Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies: post hoc analysis of a large clinical trial safety database. Haematologica. https://doi.org/10.3324/haematol.2023.283846
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
(OpenAlex Topic)
Efficacy and Resistance in CML Treatment
(OpenAlex Topic)
Lymphoid Neoplasms
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.3324/haematol.2023.283846
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: